Search - tctmd.com

Displaying 241 - 260 of 665

Sort: Relevancy | Date

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

Presentation TCT 2021

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Presenter: Ankur Kalra

October 20, 2021

News Daily News

Even as COVID-19 Care Improved in NYC, Troponin Still Signaled Higher Mortality

Caitlin E. Cox

September 28, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

News Conference News ESC 2021

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

Caitlin E. Cox

September 01, 2021

News Opinion CV Team Dispatch

September 2021 News Roundup

L.A. McKeown

September 01, 2021

News Conference News ESC 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Michael O'Riordan

August 28, 2021

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

Todd Neale

August 24, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

Early Recurrent Events After Acute MI: Clues to Origins Hint at Solutions

Caitlin E. Cox

August 10, 2021

News Daily News

Coffee Doesn’t Disturb Heart Rhythm: UK Biobank Analysis

Caitlin E. Cox

July 22, 2021

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

News Daily News

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Caitlin E. Cox

July 06, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Daily News

Complete Revascularization Best for Most ACS Patients With MVD

Michael O'Riordan

June 25, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Daily News

Final SPRINT Results Endorse Intensive BP Control

Todd Neale

May 25, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Industry News

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

May 25, 2021

Advertisement

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Even as COVID-19 Care Improved in NYC, Troponin Still Signaled Higher Mortality

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

September 2021 News Roundup

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Early Recurrent Events After Acute MI: Clues to Origins Hint at Solutions

Coffee Doesn’t Disturb Heart Rhythm: UK Biobank Analysis

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Complete Revascularization Best for Most ACS Patients With MVD

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Final SPRINT Results Endorse Intensive BP Control

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content